89Bio Inc (ETNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -182,779 | -71,275 | -367,079 | -248,725 | -99,652 |
| Depreciation Amortization | -3,433 | 465 | -9,103 | -7,353 | -5,055 |
| Accounts payable and accrued liabilities | -752 | -600 | 7,058 | 11,021 | 9,002 |
| Other Working Capital | -281 | -6,187 | -14,528 | -7,630 | -6,808 |
| Other Operating Activity | 15,083 | 5,860 | 15,829 | 6,444 | 1,629 |
| Operating Cash Flow | $-172,162 | $-71,737 | $-367,823 | $-246,243 | $-100,884 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -72 | -72 | -15 | N/A | N/A |
| Purchase Of Investment | -114,383 | -7,761 | -40,849 | -60,688 | -52,049 |
| Investing Cash Flow | $-114,455 | $-7,833 | $-40,864 | $-60,688 | $-52,049 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 9,349 | 9,349 | N/A |
| Common Stock Issued | 291,231 | 269,936 | 212,137 | 75,577 | 50,831 |
| Other Financing Activity | -1,598 | -1,030 | -2,900 | -2,745 | -1,841 |
| Financing Cash Flow | $289,633 | $268,906 | $218,586 | $82,181 | $48,990 |
| Beginning Cash Position | 126,060 | 126,060 | 316,161 | 316,161 | 316,161 |
| End Cash Position | 129,076 | 315,396 | 126,060 | 91,411 | 212,218 |
| Net Cash Flow | $3,016 | $189,336 | $-190,101 | $-224,750 | $-103,943 |
| Free Cash Flow | |||||
| Operating Cash Flow | -172,162 | -71,737 | -367,823 | -246,243 | -100,884 |
| Capital Expenditure | -72 | -72 | -15 | N/A | N/A |
| Free Cash Flow | -172,234 | -71,809 | -367,838 | -246,243 | -100,884 |